COFEPRIS Labeling Rules Are Not Optional Extras

Brands expanding from the US into Mexico often assume a translated label is a compliant label. It isn't. COFEPRIS has its own structure for health claims, required nutritional information formats, and rules about what wording counts as a therapeutic claim versus a permitted structure/function statement. Claims that pass under US DSHEA guidance can read as unauthorized medical claims in Mexico, which creates real registration delays or rejected import lots. This matters most for products entering on a tight retail calendar, since a label correction cycle can push a launch back a full quarter. The fix is not complicated, but it has to happen early: have someone who works inside the Mexican regulatory framework review claims language before artwork is finalized, not after. A manufacturer with in-house COFEPRIS experience can flag problem phrases in a first pass rather than after a rejected submission. Treat Mexican labeling as its own compliance track, not a translation task.